Related Experiment Video
Updated: Aug 11, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Organophosphate-induced delayed polyneuropathy
Marcello Lotti1, Angelo Moretto
1Department of Environmental Medicine and Public Health, University of Padua, Padova, Italy. marcello.lotti@unipd.it
Abstract:
Organophosphate-induced delayed polyneuropathy (OPIDP) is a rare toxicity resulting from exposure to certain organophosphorus (OP) esters. It is characterised by distal degeneration of some axons of both the peripheral and central nervous systems occurring 1-4 weeks after single or short-term exposures. Cramping muscle pain in the lower limbs, distal numbness and paraesthesiae occur, followed by progressive weakness, depression of deep tendon reflexes in the lower limbs and, in severe cases, in the upper limbs. Signs include high-stepping gait associated with bilateral foot drop and, in severe cases, quadriplegia with foot and wrist drop as well as pyramidal signs. In time, there might be significant recovery of the peripheral nerve function but, depending on the degree of pyramidal involvement, spastic ataxia may be a permanent outcome of severe OPIDP. Human and experimental data indicate that recovery is usually complete in the young. At onset, the electrophysiological changes include reduced amplitude of the compound muscle potential, increased distal latencies and normal or slightly reduced nerve conduction velocities. The progression of the disease, usually over a few days, may lead to non-excitability of the nerve with electromyographical signs of denervation. Nerve biopsies have been performed in a few cases and showed axonal degeneration with secondary demyelination. Neuropathy target esterase (NTE) is thought to be the target of OPIDP initiation. The ratio of inhibitory powers for acetylcholinesterase and NTE represents the crucial guideline for the aetiological attribution of OP-induced peripheral neuropathy. In fact, pre-marketing toxicity testing in animals selects OP insecticides with cholinergic toxicity potential much higher than that to result in OPIDP. Therefore, OPIDP may develop only after very large exposures to insecticides, causing severe cholinergic toxicity. However, this was not the case with certain triaryl phosphates that were not used as insecticides but as hydraulic fluids, lubricants and plasticisers and do not result in cholinergic toxicity. Several thousand cases of OPIDP as a result of exposure to tri-ortho-cresyl phosphate have been reported, whereas the number of cases of OPIDP as a result of OP insecticide poisoning is much lower. In this article, we mainly discuss OP pesticide poisoning, particularly when caused by chlorpyrifos, dichlorvos, isofenphos, methamidophos, mipafox, trichlorfon, trichlornat, phosphamidon/mevinphos and by certain carbamates. We also discuss case reports where neuropathies were not convincingly attributed to fenthion, malathion, omethoate/dimethoate, parathion and merphos. Finally, several observational studies on long-term, low-level exposures to OPs that sometimes reported mild, inconsistent and unexplained changes of unclear significance in peripheral nerves are briefly discussed.
Insights
Organophosphate-induced delayed polyneuropathy (OPIDP) is a rare nerve condition caused by certain organophosphorus esters. It leads to progressive weakness and sensory loss weeks after exposure, with potential for long-term effects.
Area of Science:
- Neurotoxicology
- Environmental Health
- Occupational Medicine
Background:
- Organophosphate-induced delayed polyneuropathy (OPIDP) is a distinct neurological disorder.
- It results from exposure to specific organophosphorus (OP) esters, often encountered in pesticides and industrial chemicals.
- OPIDP is characterized by axonal degeneration in the peripheral and central nervous systems, typically manifesting 1-4 weeks post-exposure.
Purpose of the Study:
- To review the clinical manifestations, electrophysiological findings, and pathological characteristics of OPIDP.
- To discuss the mechanism of OPIDP, focusing on the role of neuropathy target esterase (NTE) inhibition.
- To differentiate OPIDP caused by OP pesticides from that caused by non-pesticidal OP compounds, such as triaryl phosphates.
Main Methods:
- Review of human and experimental data on OPIDP.
- Analysis of clinical case reports and observational studies.
- Discussion of toxicological principles, including the ratio of inhibitory powers for acetylcholinesterase and NTE.
Main Results:
- OPIDP presents with distal sensory and motor disturbances, including pain, numbness, weakness, and gait abnormalities.
- Electrophysiological studies show reduced nerve excitability and axonal degeneration, with nerve biopsies revealing secondary demyelination.
- Non-pesticidal triaryl phosphates, like tri-ortho-cresyl phosphate, have caused more widespread OPIDP than OP insecticides.
- Specific OP pesticides like chlorpyrifos and dichlorvos are discussed as potential causes.
Conclusions:
- OPIDP is a serious neurological outcome of exposure to certain OP compounds, with varying etiological agents.
- The ratio of inhibition of acetylcholinesterase versus NTE is critical for understanding OP-induced neuropathies.
- While recovery is possible, severe cases can lead to permanent neurological deficits, particularly spastic ataxia.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Botulism

